[go: up one dir, main page]

BG35326A3 - Method for stabilizing of prostaglindines or their derivatives - Google Patents

Method for stabilizing of prostaglindines or their derivatives

Info

Publication number
BG35326A3
BG35326A3 BG029696A BG2969675A BG35326A3 BG 35326 A3 BG35326 A3 BG 35326A3 BG 029696 A BG029696 A BG 029696A BG 2969675 A BG2969675 A BG 2969675A BG 35326 A3 BG35326 A3 BG 35326A3
Authority
BG
Bulgaria
Prior art keywords
series
prostaglandin
derivatives
stabilizing
dolo
Prior art date
Application number
BG029696A
Other languages
Bulgarian (bg)
English (en)
Inventor
Donald Monkhouse
Original Assignee
Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware filed Critical Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Publication of BG35326A3 publication Critical patent/BG35326A3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG029696A 1974-04-19 1975-04-17 Method for stabilizing of prostaglindines or their derivatives BG35326A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US462213A US3927197A (en) 1974-04-19 1974-04-19 Tertiary alcohol stabilized E-series prostaglandins

Publications (1)

Publication Number Publication Date
BG35326A3 true BG35326A3 (en) 1984-03-15

Family

ID=23835600

Family Applications (1)

Application Number Title Priority Date Filing Date
BG029696A BG35326A3 (en) 1974-04-19 1975-04-17 Method for stabilizing of prostaglindines or their derivatives

Country Status (23)

Country Link
US (1) US3927197A (fi)
JP (1) JPS5337408B2 (fi)
AR (1) AR213271A1 (fi)
AT (1) AT348130B (fi)
AU (1) AU470631B2 (fi)
BE (1) BE828065A (fi)
BG (1) BG35326A3 (fi)
CA (1) CA1034044A (fi)
CS (1) CS191244B2 (fi)
DD (1) DD119131A5 (fi)
DE (1) DE2516105C3 (fi)
DK (1) DK138161B (fi)
ES (1) ES436613A1 (fi)
FI (1) FI62220C (fi)
FR (1) FR2267760B1 (fi)
GB (1) GB1474852A (fi)
HU (1) HU175405B (fi)
IE (1) IE40829B1 (fi)
IL (1) IL46994A (fi)
LU (1) LU72320A1 (fi)
NL (1) NL158384B (fi)
PH (1) PH11697A (fi)
SE (1) SE428528B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197257A (en) * 1976-02-04 1980-04-08 The Upjohn Company 6-Keto prostaglandin derivatives
US4169895A (en) * 1976-09-28 1979-10-02 Pfizer Inc. Antisecretory 16,16-dimethyl-17-oxaprostaglandins
US4098805A (en) * 1977-04-11 1978-07-04 The Upjohn Company 9-deoxy-9-methylene-pgf-type amides
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
ZA837627B (en) * 1982-10-15 1984-06-27 Procter & Gamble Storage stable topical pharmaceutical composition containing low dielectric solvents
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
PT725642E (pt) * 1993-10-27 2000-05-31 Upjohn Co Prostaglandina e 1 estabilizada
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease
US20050203086A1 (en) * 2004-03-04 2005-09-15 Pfizer Inc. Methods of treatment using an EP2 selective receptor agonist
WO2008134828A2 (en) 2007-05-04 2008-11-13 Katholieke Universiteit Leuven Tissue degeneration protection
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
AT515356B1 (de) * 2014-01-30 2015-11-15 Gebro Holding Gmbh Stabile alkoholische Lösung von Alprostadil
MX2020008680A (es) 2018-02-21 2020-09-25 Ai Therapeutics Inc Terapia de combinacion con apilimod y agentes glutamatergicos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644638A (en) * 1970-08-24 1972-02-22 American Home Prod Compositions and methods for relieving bronchial spasm with prostanoic acids and esters
US3749800A (en) * 1971-11-01 1973-07-31 Upjohn Co Stable composition for dispensing pge2
US3833725A (en) * 1972-12-08 1974-09-03 Syntex Corp Dialkylated glycol compositions and medicament preparations containing same

Also Published As

Publication number Publication date
DE2516105C3 (de) 1982-01-07
DE2516105A1 (de) 1975-10-23
CA1034044A (en) 1978-07-04
ATA278875A (de) 1978-06-15
SE7503723L (sv) 1975-10-20
GB1474852A (en) 1977-05-25
BE828065A (fr) 1975-10-17
DE2516105B2 (de) 1981-01-08
AU470631B2 (en) 1976-03-25
NL158384B (nl) 1978-11-15
FI62220B (fi) 1982-08-31
IE40829L (en) 1975-10-19
SE428528B (sv) 1983-07-11
PH11697A (en) 1978-05-24
DK138161B (da) 1978-07-24
HU175405B (hu) 1980-07-28
IL46994A (en) 1979-10-31
JPS5337408B2 (fi) 1978-10-09
FR2267760B1 (fi) 1978-08-04
IE40829B1 (en) 1979-08-29
NL7504274A (nl) 1975-10-21
AR213271A1 (es) 1979-01-15
AT348130B (de) 1979-01-25
CS191244B2 (en) 1979-06-29
FR2267760A1 (fi) 1975-11-14
FI62220C (fi) 1982-12-10
DD119131A5 (fi) 1976-04-12
US3927197A (en) 1975-12-16
LU72320A1 (fi) 1976-03-17
ES436613A1 (es) 1977-04-16
DK138161C (fi) 1979-01-02
FI751108A (fi) 1975-10-20
IL46994A0 (en) 1975-06-25
DK167075A (fi) 1975-10-20
AU7987775A (en) 1976-03-25
JPS50145515A (fi) 1975-11-21

Similar Documents

Publication Publication Date Title
BG35326A3 (en) Method for stabilizing of prostaglindines or their derivatives
BG28233A3 (en) Means for growth plant regulation
BG33274A3 (en) Method for obtaining of ethers
BG31221A3 (en) Sorbent material- carrier and method for its obtaining
US4201873A (en) 9-Deoxy-9,10-didehydro-PGD2 analogs
AT347928B (de) Verfahren zur herstellung von neuen araliphatischen stickstoffverbindungen
ATE553T1 (de) Verfahren zur herstellung von nitroparaffinen durch nitrierung von aethan in der gasphase.
KR850000391A (ko) 프로스타 글란딘 화합물의 제조방법
ATA554975A (de) Verfahren zur herstellung von neuen derivaten eines antibiotikums
GB1190903A (en) Water-Repellent Cement
BG33288A3 (en) Method for obtaining of 6- methyl- 8 (substituated)- methylergolin
BG40485A3 (en) Method for preparing microporous materials
ES422831A1 (es) Procedimiento para la obtencion de derivados de ciclopenta-no.
JPS5217784A (en) Support structure for slip thickness vibrator
FR2326184A1 (fr) Analogues de prostaglandines et leur preparation
BE831097R (fr) Stabilisation de matieres organiques au moyen de derives du pyrazole
ATE1143T1 (de) Prostan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutischen zusammensetzungen.
GB1232317A (fi)
SE7508943L (sv) Porstaglandinderivat
SU461913A1 (ru) Способ изготовлени газобетонной массы
BG28543A3 (bg) Средство за регулиране растежа на растенията
Melville The Eve They Have Painted
CH437275A (de) Verfahren zur Herstellung eines Gemisches von (3,2-c)-Pyrazol-Verbindungen der Pregnenreihe
GB1202400A (en) Process for the preparation of cyclic nitrile sulfite adducts
GB1387328A (en) Stabilized lactone compositions